Founded in 1985, HYPRED now has more than 400 employees in over 40 countries and achieved a turnover of more than €100 million in 2015.
This transaction is in line with the development strategy of the company which intends to accelerate its international expansion. HYPRED will also increase its investment in R&D, biosecurity (detergents and disinfectants) and nutritional supplements for animals, with the ambition of becoming the international leader of these markets.
HYPRED’s strategy will also involve the development of existing plants and an acquisition program in new sectors and territories. The first step will be the renovation of the Dinard Innovation Center in 2017, which includes a research laboratory and a testing & application center.
Sébastien Bossard, President of HYPRED said: “Over the past 30 years, Hypred has grown into a European leader of its market, and we will be further helped by Ardian’s expertise, network and support. Our shareholding structure, which allows management to take a stake in the company, has allowed all of us to be a part of the company’s success. Ardian has an ambitious development strategy for HYPRED and will be a true partner, helping us to expand our international reach and strengthen our innovation capabilities while giving great importance to human capital. This partnership will lead to major development projects which will see HYPRED and Ardian working together and sharing values and expertise.”
ABOUT ARDIAN
Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of US$60 billion managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fuelling growth in economies across the world. Ardian’s investment process embodies three values: excellence, loyalty and entrepreneurship. Ardian maintains a truly global network, with more than 430 employees working through twelve offices in Beijing, Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, New York, Paris, San Francisco, Singapore and Zurich. The company offers its 550 investors a diversified choice of funds covering the full range of asset classes, including Ardian Funds of Funds (primary, early secondary and secondary), Ardian Private Debt, Ardian North America Direct Buyout, Direct Funds (Ardian Mid Cap Buyout, Ardian Expansion, Ardian Growth, Ardian Co-Investment), Ardian Infrastructure, Ardian Real Estate and customized mandate solutions with Ardian Mandates.
ABOUT HYPRED
Founded in 1985, HYPRED has extensive industry expertise in the formulation, production and commercialization of biosecurity solutions, disinfection and hygiene for professionals in the food and agriculture industries.
Hypred is now present in over 40 countries and has more than 400 employees worldwide. HYPRED benefits from an high quality industrial tool which gives the company the possibility to support its clients worldwide. Its proprietary production sites and partners are located in France, Spain, Italy, Germany, Poland, Argentina, Brazil, Colombia, Peru, Turkey, USA and South Africa. In 2015, Hypred achieved a turnover of more than €100 million.